Why the study?
Aortic stenosis requires lifelong disease management, and advancements in therapeutic approaches and prosthetic valve technology continue to evolve.
This review synthesizes recent advancements in therapeutic approaches and prosthetic valve technology for the lifelong management of aortic stenosis.
Answers are grounded in this paper and cite their sources.
Review updates AS therapeutic landscape; extends prior syntheses but leaves open comparative long-term data.
Aortic stenosis (AS) poses significant risks to patient survival and quality of life. The management of AS extends beyond restoring valve function to encompass lifelong disease management. While curative treatments exist, advancements in therapeutic approaches and prosthetic valve technology continue to evolve. This review synthesizes recent developments in AS treatment modalities, prosthetic valve innovations, and their clinical implications, delineating the current therapeutic landscape.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: